Krishna Pada Sarker
- Molecular Biology
- Pharmacology top 2%
- Cellular and Molecular Neuroscience top 10%
- Surgery
- Pathology and Forensic Medicine top 10%
- Co-authors
- Ikuro MaruyamaIsao KitajimaMasanori NakataI MaruyamaKi‐Young LeeKamal Krishna BiswasTeruto HashiguchiShirin Bonni
- Topics
- Blood Coagulation and Thrombosis Mechanisms (7 papers)Cannabis and Cannabinoid Research (5 papers)Neuroscience and Neuropharmacology Research (4 papers)
- Partner nations
- JapanCanadaUnited States
In The Last Decade
Krishna Pada Sarker
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 502
- Pharmacology 406
- Cellular and Molecular Neuroscience 217
- Surgery 137
- Pathology and Forensic Medicine 119
Countries citing papers authored by Krishna Pada Sarker
This map shows the geographic impact of Krishna Pada Sarker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Pada Sarker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Pada Sarker more than expected).
Fields of papers citing papers by Krishna Pada Sarker
This network shows the impact of papers produced by Krishna Pada Sarker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Pada Sarker. The network helps show where Krishna Pada Sarker may publish in the future.
Co-authorship network of co-authors of Krishna Pada Sarker
This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Pada Sarker. A scholar is included among the top collaborators of Krishna Pada Sarker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Pada Sarker. Krishna Pada Sarker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 19 | |
| 3 | 41 | |
| 4 | 18 | |
| 5 | 43 | |
| 6 | 38 | |
| 7 | 43 | |
| 8 | 60 | |
| 9 | 11 | |
| 10 | 30 | |
| 11 | 43 | |
| 12 | 91 | |
| 13 | 80 | |
| 14 | 41 | |
| 15 | 89 | |
| 16 | 9 | |
| 17 | 50 | |
| 18 | 33 | |
| 19 | 94 | |
| 20 | 12 |
About Krishna Pada Sarker
Krishna Pada Sarker is a scholar working on Hematology, Energy Engineering and Power Technology and Applied Microbiology and Biotechnology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Cannabis and Cannabinoid Research (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). The work is most often cited by research in Pharmacology (406 citations), Cellular and Molecular Neuroscience (217 citations) and Toxicology (39 citations). Krishna Pada Sarker has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Ikuro Maruyama, Isao Kitajima, Masanori Nakata, I Maruyama, Ki‐Young Lee, Kamal Krishna Biswas, Teruto Hashiguchi, Shirin Bonni, Munekazu Yamakuchi and Kazuyo Yamaji. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.